-+ 0.00%
-+ 0.00%
-+ 0.00%

Kyodo Pharmaceutical announced on October 26 that revenue for the third quarter of 2026 was 168 million yuan, up 10.26% year on year; net profit loss to mother was 15.9.296 million yuan, a year-on-year decrease. Revenue for the first three quarters of 2026 was $515 million, up 13.08% year on year; net profit loss to mother was 487.71 million yuan, an increase in the year-on-year loss.

Zhitongcaijing·10/26/2026 08:01:07
Listen to the news
Kyodo Pharmaceutical announced on October 26 that revenue for the third quarter of 2026 was 168 million yuan, up 10.26% year on year; net profit loss to mother was 15.9.296 million yuan, a year-on-year decrease. Revenue for the first three quarters of 2026 was $515 million, up 13.08% year on year; net profit loss to mother was 487.71 million yuan, an increase in the year-on-year loss.